OBO_ID (LABEL):	CHEBI_3752 (clomiphene)

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC5359891	3/2017	S84-PMC5359891	['inclusion criteria are women who meet the following:\naged 18–38 years\nliving in southampton, singapore or auckland\nin southampton and auckland, planning to have future maternity care in southampton and auckland, respectively\nin singapore, willing to Deliver at the national university hospital\nwomen planning to Conceive within 6\xa0months (but Conception up to 12\xa0months after phenotyping will still be included)\nin singapore only women of chinese, malay and indian ethnicity, or of mixed chinese/malay/indian ethnicity will be included\nable to provide written, informed consent\nexclusion criteria are:\nPregnant or Lactating at recruitment (women who are currently breastfeeding will be excluded, but no washout period from the end of breastfeeding will be required before study start)\nassisted fertility apart from those taking Clomiphene or Letrozole alone\nwomen with pre-existing type-1 or type-2 diabetes (fasting Plasma Glucose concentration ≥7.0\xa0mmol/l or post ogtt 2-h Plasma Glucose concentration ≥11.1\xa0mmol/l)\noral or implanted Contraception currently or in the last month, or with an Intrauterine contraceptive device in situ\nmetformin or systemic Steroids currently or in the last month\nAnticonvulsant Medication currently or in the last month\ntreatment for hiv, hepatitis b or c currently or in the last month\nknown serious Food allergy\nwithdrawal criteria are:\nthe participant wishes to discontinue participation in the study\nthe participant is unwilling or unable to comply with the protocol (including attendance at study visits, having study measures and biosampling)\nan overall uptake level of intervention/control Nutritional Drink of less than 60% evidenced by sachet counting\nthe participant is Pregnant before or at Preconception visit 2\nthe participant suffers a Miscarriage (Pregnancy loss before 24\xa0weeks’ Gestation) or ectopic Pregnancy.']	N/A	N/A	[('GO_0007567', 'parturition', 250, 'deliver'), ('GO_0007631', 'feeding behavior', 312, 'conceive'), ('GO_0007620', 'copulation', 342, 'conception'), ('GO_0007565', 'female pregnancy', 601, 'Pregnant'), ('GO_0007594', 'puparial adhesion', 613, 'lactating'), ('CHEBI_3752', 'clomiphene', 827, 'clomiphene'), ('CHEBI_6413', 'letrozole', 841, 'letrozole'), ('UBERON_0001969', 'blood plasma', 916, 'plasma'), ('CHEBI_17234', 'glucose', 923, 'glucose'), ('UBERON_0001969', 'blood plasma', 974, 'plasma'), ('CHEBI_17234', 'glucose', 981, 'glucose'), ('GO_0006936', 'muscle contraction', 1035, 'contraception'), ('UBERON_0022293', 'reproductive gland secretion', 1092, 'intrauterine'), ('CHEBI_35341', 'steroid', 1156, 'steroids'), ('CHEBI_35624', 'azaspiro compound', 1196, 'Anticonvulsant'), ('CHEBI_60211', 'compound Z', 1211, 'medication'), ('CHEBI_33290', 'food', 1334, 'food'), ('CHEBI_7495', 'nefazodone hydrochloride', 1630, 'nutritional'), ('CHEBI_35702', 'diethyl ether', 1642, 'drink'), ('GO_0007565', 'female pregnancy', 1713, 'pregnant'), ('GO_0007565', 'female pregnancy', 1735, 'preconception'), ('GO_0046660', 'female sex differentiation', 1783, 'miscarriage'), ('GO_0007565', 'female pregnancy', 1796, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1828, 'gestation'), ('GO_0007565', 'female pregnancy', 1850, 'pregnancy')]
